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Abstract
Background: Mutations in the LGI1 gene predispose to a rare, hereditary form of temporal epilepsy. Currently, little
is known about the temporal and spatial expression pattern of Lgi1 during normal embryogenesis and so to define
this more clearly we used a transgenic mouse line that expresses GFP under the control of Lgi1 cis-regulatory
elements.
Results: During embryonic brain growth, high levels of Lgi1 expression were found in the surface ectoderm, the
neuroepithelium, mesenchymal connective tissue, hippocampus, and sensory organs, such as eye, tongue, and the
olfactory bulb. Lgi1 was also found in the cranial nerve nuclei and ganglia, such as vestibular, trigeminal, and
dorsal ganglia. Expression of Lgi1 followed an orchestrated pattern during mouse development becoming more
subdued in areas of the neocortex of the mid- and hind-brain in early postnatal animals, although high expression
levels were retained in the choroid plexus and hippocampus. In late postnatal stages, Lgi1 expression continued to
be detected in many areas in the brain including, hippocampus, paraventricular thalamic nuclei, inferior colliculus,
and the cerebral aqueduct. We also showed that Lgi1-expressing cells co-express nestin, DCX, and beta-III tubulin
suggesting that Lgi1-expressing cells are migratory neuroblasts.
Conclusion: These observations imply that Lgi1 may have a role in establishing normal brain architecture and
neuronal functions during brain development suggesting that it may be involved in neurogenesis and neuronal
plasticity, which become more specifically defined in the adult animal.
Background
The Lgi1 gene [1] predisposes to the development of a rare
form of partial epilepsy with autosomal dominant inheri-
tance and high penetrance [2], referred to both as Autoso-
mal Dominant Partial Epilepsy with Auditory Features
(ADPEAF) [3] and Autosomal Dominant Temporal Lobe
Epilepsy (ADTLE) [4]. It has also been shown recently that
Lgi1 is the auto antigen responsible for limbic encephalitis,
previously thought to be caused by autoantibodies against
voltage gated potassium channels [5]. These patients are
part of the group of autoimmune synaptic encephalopa-
thies and exhibit seizures and neuropsychiatric disorders.
Lgi1 is a secreted protein [6-8] and has also been impli-
cated in cell movement and invasion in glioma cells [9]
through suppression of the ERK signaling pathway that
results in down regulation of matrix metalloproteinases
[10]. Recent studies have shown that Lgi1 interacts with a
number of different proteins that are related to synaptic
function [11-13], notably members of the ADAM family of
proteins (ADAM11, ADAM22 and ADAM23), which
represent some of the Lgi1 receptors [12-14]. Most recently
[15], Lgi1 was also shown to interact with the Nogo recep-
tor 1 (NgR1) and enhances neuronal growth on myelin
based inhibitory substrates and antagonizes myelin-induced
growth cone collapse. Mutant null mice for Lgi1 show
early onset seizures [16-18], as do mice null for ADAM22
and ADAM23 [19,20]. Thus, Lgi1 represents the only her-
editary epilepsy predisposition gene which is not a channe-
lopathy and offers the opportunity to understand different
mechanisms behind seizures in these individuals.
Analysis of mutant null mice has demonstrated that
Lgi1 is clearly involved in synapse transmission [16,17],
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although, whether it also plays a role in normal brain
development is not clear. Although abnormal structures
within the brains of ADLTE patients have been reported
by several groups [4,21-23], the level of resolution
afforded using current imagining technologies precludes
detailed evaluations of these potential abnormalities.
Clearly, a better understanding of the cell lineages
which express Lgi1 during mammalian brain develop-
ment will be important in defining its overall function.
Extensive analysis of gene expression in the brain of
adult mice demonstrated that the hippocampus and cor-
tex were the predominant regions expressing Lgi1
[24,25], even though the resolution of the cell lineages
involved was relatively low using this approach. Immuno-
histochemical studies in humans have confirmed these
broad observations, although many of the antibodies
used in these studies have either been shown to cross
react with other members of the Lgi1 family of proteins
[8] or have not been tested for cross reactivity. To over-
come this potential limitation, we developed a BAC
transgenic mouse in which the GFP reporter gene was
placed under the control of Lgi1 cis-regulatory elements
[8]. In these BAC transgenics the GFP gene is expressed
in cells which have the transcriptional capability of
expressing the endogenous Lgi1 gene, and these cells can
be identified using conventional immunohistochemistry.
This system has been extensively used as part of the
GENSAT program to define expression patterns of genes
expressed in the central nervous system of adult mice
[26]. To date, however, there have been no reported stu-
dies of Lgi1 expression patterns at the cellular level dur-
ing embryonic development. In this report, we describe
an immunohistochemical study of the developing brain
and associated structures of the nervous system from
embryonic days E9.5-E18.5 and postnatal days P1-P20.
These studies show that Lgi1 expression is widespread in
the developing brain. More interestingly, co-staining stu-
dies shown that Lgi1 is expressed in migratory neuroblast
cell lineages.
Results
The Lgi1 BAC transgenic system
BAC transgenic technology is now well established [26]
and has been used extensively to define gene expression
patterns through the insertion of a GFP reporter into the
target gene in the context of its endogenous cis-regulatory
elements [26]. Thus, with the caveat that regulatory ele-
ments that lie some distance away from the promoter may
not be present on the BAC, any cell capable of activating
the endogenous promoter of a given gene will also activate
the reporter gene carried on the transgenic BAC clone.
This system has been developed to overcome many short-
comings of antibodies, whose limitations may include, low
specificity for the target protein, cross reactivity with
homologous proteins, or poor recognition of the endogen-
ous protein in its native conformation. It should be noted,
however, that GFP is only a reporter for endogenous gene
expression patterns and does not define the intracellular
localization of the protein it reports. As such, the intracel-
lular fluorescence signal reflects the ubiquitous distribu-
tion of GFP protein. Typically, multiple tandem BAC
integrations occur during construction of the transgenic
animals which fortuitously provides a strong GFP signal.
In our case, >40 copies of the BAC are present in mice
used in this study [8]. This reporter system, therefore, has
the added advantage of allowing the visualization of
expression patterns for genes which normally show low
levels of expression or which, like Lgi1 [6,8], are normally
rapidly secreted and so may be more difficult to visualize
using traditional antibodies. Importantly, since the BAC
shows multiple tandem integration events [8], the intensity
of the GFP fluorescence does not reflect the intensity of
the endogenous gene expression, although relative expres-
sion levels between different cells in the same field can be
used as a means of determining comparative Lgi1 expres-
sion levels.
Lgi1 expression during embryonic development
To investigate the distribution of Lgi1 expression in the
mouse brain during development, we collected different
embryonic/postnatal stage brains from the EGFP-reporter
BAC transgenic mice, which we previously showed can be
used to define Lgi1 expression patterns at the cellular level
[8]. In this analysis we focused on the brain regions that
have been implicated in epilepsy, but did not restrict the
analysis to the development of specific systems. If Lgi1
influences normal development, then establishing its over-
all expression pattern during brain development would be
important. Most of the sections used in this study were
mid-coronal and mid-sagittal, since these planes allow a
symmetrical view of the tissue that permits a comprehen-
sive visualization of areas of interest, such as neocortex,
hippocampus, nerve ganglia, and sensory organs. Using
this strategy, we characterized Lgi1 expression patterns
during early development (E9.5-E18.5). A summary of
temporal expression patterns in major regions of the brain
is given in Figure 1 and specific details at each develop-
mental stage are described below.
E9.5 represents the earliest embryonic stage in our ana-
lysis, partly because of the technical difficulties associated
with processing earlier embryos, and partly because prior
to this stage, brain development is still rudimentary. At
E9.5, the neural tube is still developing and the structures
that will eventually give rise to the brain are largely
absent. At this embryonic stage, Lgi1 was prominently
expressed in the primitive eye (Figure 2A). Lgi1 was also
detected in the skin ectoderm (surface ectoderm), the
mesenchymal connective tissue, the optic vesicle, and the
Silva et al. BMC Neuroscience 2011, 12:43
http://www.biomedcentral.com/1471-2202/12/43
Page 2 of 14
neuroepithelium lining the neural tube (Figure 2A). Fol-
lowing neural tube closure at embryonic stage E10.5,
Lgi1 expression was found in sensory and secretory
organs, such as olfactory placode (Figure 2B.1) and the
peripheral margin of Rathke’s pouch (Figure 2B.2), which
gives rise to the anterior pituitary. Additionally, strong
expression could be seen along the roof of the hindbrain
(Figure 2B.3) and midbrain mesenchymal connective
tissue (Figure 2B.4). Other notable areas of Lgi1 expres-
sion at E10.5 included ganglionic tissues, such as facio-
acoustic ganglion (Figure 2C.1) and dorsal ganglia (Figure
2B.5). In the forebrain, Lgi1 showed strong expression in
the skin ectoderm, lamina terminalis, and the mandibular
component of the first branchial arch (Figure 2B.1 and
2B.2), which gives rises the glands of the anterior two
thirds of the tongue and ossicles of the middle ear.
Lgi1 expression became notably more extensive
throughout the developing brain with increased expres-
sion in the forebrain, primarily along the wall of the tel-
encephalic vesicle, although weak expression of Lgi1 was
seen in the primitive neocortex. At embryonic stage
E11.5, several cranial nerve ganglia showed prominent
expression, particularly in the relatively large trigeminal
ganglion (Figure 3A.1). In addition, Lgi1 expression was
strong in the optic stalk and optic cup (Figure 3A.2). As
the brain developed, Lgi1 expression at E12.5 was
observed in the roof of the neopallial cortex (future cer-
ebral cortex), choroid plexus, and areas of the midbrain,
such as the pretectal area, the anterior ventral tegmen-
tum, tectum, and superior colliculus (Figures 3B.1 and
3B.2). More caudal structures, such as the inferior colli-
culus and areas of the hindbrain (the pons and cerebel-
lar neuroepithelium) showed moderate levels of Lgi1
expression.
By embryonic stage E13.5, Lgi1 expression was
observed in the roof of the neopallial cortex, areas of the
diencephalon and cranial nerve ganglia, such as trigem-
inal, facio-acoustic, and vagus. Strong expression was
found in the periventricular zone, ganglionic eminence
(Figure 4A.1), and medulla oblongata (Figure 4A.2).
Expression in the ganglionic eminence was now detected
for the first time. The ganglionic eminence contains pro-
genitor cells that are destined to become part of the
olfactory cortex as well as the striatum [27,28]. Lgi1 was
also found to be expressed in several non neural tissues,
such as the tongue (Figure 4A.4) and lower molar region
(Figure 4B.1) which represents the first signs of ossifica-
tion. Lgi1 was now strongly expressed in the choroid
plexus (Figure 4A.3).
E14.5 Lgi1 expression began to subside in the olfac-
tory lobes by this embryonic stage, as soon as the bulbs
became apparent. Lgi1 was also detected in cells of the
emerging hippocampus, which appeared as a thin line of
cells (Figure 5A) surrounding the cortical neuroepithe-
lium. Within the telencephalon, high levels of expression
were found in the basal telencephalic plate, specifically
in the posterior region (Figure 5B.1). Cells from this
area give rise to the corpus striatum, which becomes
part of the basal ganglia. Moderate Lgi1 expression was
seen in the cortical neuroepithelium and periventricular
Figure 1 Lgi1 expression during the developing and the postnatal mouse brain. A: RT-PCR analysis of Lgi1 expression in the brain from
embryonic days E10.5 to E18.5 and postnatal cortex P1 to P20. B: Summary of the spatial and temporal expression of Lgi1 in mouse sensory
organs during brain embryogenesis.
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zone (Figure 5B.2). The superior sagittal sinus mesench-
ymal connective tissue and skin ectoderm, as well as the
thalamus, was generally devoid of Lgi1 expression at
this stage, although several structures immediately
superior to the thalamus, including the pretectum,
showed moderate levels of Lgi1 expression. Expression
in the developing cerebellum at this stage of develop-
ment was weak. In contrast, strong levels of Lgi1 expres-
sion were seen in septal neuroepithelium, cranial nerve
ganglia of the vestibulocochlear and vagus, vomeronasal,
olfactory and maxillary nerves as well as the choroid
plexus. At this point of the mouse development, isolated
patches of expression were also seen in non-neuronal
organs, such as the cartilage primordium of the vertebra,
the tongue and molar tooth, demonstrating that Lgi1
expression is not restricted to neuronal tissues as sug-
gested previously in adult animals [8].
By E15.5 (Figure 6), Lgi1 expression patterns largely
reflected those observed at E13.5 and E14.5, although as
embryonic growth continued, the regions showing Lgi1
expression became more extensive with the increasing
size of the brain. Deep within the telencephalon, the
ganglionic eminence (Figure 6A.1) continued to show
Lgi1 expression. Strong expression was also seen in the
Figure 2 Photomicrographs showing the expression of Lgi1. In A E9.5 embryos showing a coronal view of the cephalic region with high-
level Lgi1 expression in the primitive eye (pe). In B, a sagittal view of the E10.5 mouse whole embryo (anti-GFP-peroxidase stained) indicating
regions seen in Figures B.1-5 showing the dorsoventral patterning of Lgi1 expression in the brain. The highest levels of Lgi1 expression were
seen (B.3) in the roof of the hindbrain (rh), (B.4) mesenchymal connective tissue (cm) and (B5) dorsal root ganglion (drg). In C, a frontal section
(H & E staining) of an E10.5 mouse brain identifying regions shown in Figure (C.1), identifying Lgi1 expression in the otic vesicle (ov) and facio-
acoustic ganglion (fag). Other abbreviations: Skin ectoderm (se), neuroepithelium (ne), neural tube (ne), telencephalic vesicle (tv), wall of
telencephalic vesicle (wtv), olfactory placode (op), lamina terminalis (lt), peripheral margin of the Rathke’s Pouch (pmrp), mandibular component
of the first brachial arch (mc), 4th ventricle (4thv), neural lumen (nl). Scale bars = 100 μm (B.4, C.1), 50 μm (A, B.1, B.2), 10 μm (B.5), 5 μm (B.3).
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ventricular zone (Figure 6A.1). Thalamic cells appear
not to express Lgi1, although some areas showed rela-
tively weak expression. Robust Lgi1 expression was
found in the lower tegmental neuroepithelium, mamma-
lary body, and posterior hypothalamus neuroepithelium
(Figure 6A.2). High levels of Lgi1 expression were now
found within the subpial and parenchyma layers of the
medulla oblongata (Figure 6A.3). Expression in the eye
(Figure 6B.1), tongue (taste buds) (Figure 6B.2), Merck-
el’s cartilage, jaw, and ganglia, as well as in the sphenoid
palatine ganglion (Figure 6B.3), remained strong at this
stage.
By embryonic day 18.5 (Figure 7), Lgi1 expression pat-
terns became more defined in specific regions, such as
the subventricular zone, hippocampus, choroid plexus,
sensory organs, and nerve ganglia. Strong expression
was seen in the hypothalamus regions, including the
anterior hypothalamic area, paraventricular hypothala-
mic nucleus, and zona incerta (Figure 7A.1). The cere-
bral cortex showed low levels of expression, although a
thin layer of cells expressing Lgi1 could be seen above
the genu of the corpus callosum, which marked the for-
mation of the subplate. Figure 7A.2 shows expression of
Lgi1 in the cortical plate, intermediate cortical zone, and
subventricular zone. By this time, the hippocampus had
also undergone further differentiation, but retains Lgi1
expression, albeit at lower levels, remaining highly
expressed in the dentate gyrus (Figure 7A.3). Lgi1 had
been weakly expressed in thalamus in the earlier
embryonic stages and still appeared weak in the later
embryonic stages. Strong expression continues to be
seen in the choroid plexus.
Lgi1 expression in the early postnatal stages of the
murine brain
At postnatal day one (P1), moderate to low expression
of Lgi1 was present in several areas described above
(Figure 1). The lowest levels of Lgi1 expression were
seen along the neocortex, and were almost undetectable
in the frontal and cingulated cortices. Expression levels
were weak in the basal ganglia, although the stria termi-
nalis showed higher levels of Lgi1 expression (Figure
8A.1). Thalamic and hypothalamic areas also showed
very weak to absent expression, even though low-level
expression was detected around the third ventricle,
which represents the medial habenular nuclear. The hip-
pocampus now showed weak expression in CA1 and
CA3 areas, although moderate expression was retained
Figure 3 Lgi1 expression at embryonic stages E11.5 and E12.5.
A Coronal section (H & E staining) identifies regions seen in Figures
A.1 and A.2. In A.1, Lgi1 expression was seen in the trigeminal
ganglion (tg), optic stalk (os), and optic cup (op). B Sagittal view of
the E12.5 mouse whole embryo identifying regions seen in Figures
B.1 and B.2. In B.1, a midsagittal section (anti-GFP-peroxidase
stained) of the cephalic region shows Lgi1 expression in the
choroid plexus (chp), inferior colliculi (ic), and cerebellar plate (cbp).
In B.2, a midsagittal section at the cephalic region of the embryo
showing Lgi1 expression in the pretectum (pt), ventral tegmental
area (vt) and midbrain (mb). Scale bars = 100 μm (B.1, B.2), 50 μm
(A.1, A.2).
Figure 4 Lgi1 expression at embryonic stage E13.5. A Sagittal
view (anti-GFP-peroxidase stained) of the whole embryo indicating
areas of Lgi1 expression seen in Figures A.1 - A.4. A.1 Lgi1
expression is seen in cells in the periventricular zone (pvz),
ganglionic eminence (ge) and septum neuroepithelium (sne). Lgi1 is
also expressed in A.2 the medulla oblongata (mo) and A.3 the
choroid plexus adjacent to the 4th ventricle (4thv). A.4 In the oral
cavity, Lgi1 is expressed in the tongue (tg). B Frontal section (H & E
staining) indicating the area seen in Figure B.1. B.1 Frontal section
showing Lgi1 expression throughout the tongue (tg), mandibular
process and lower molar region (pm). Scale bars = 100 μm.
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in the dentate gyrus as well as in the inferior tectal neu-
roepithelium and superior cerebellar peduncle (Figures
8A.2 and 8A.3).
Within the cerebral cortex at stage P5, moderate
expression levels were seen in layers II/III and V of the
neocortex. Expression in the hippocampus was main-
tained unchanged at this stage, with moderate levels
seen in the dentate gyrus. We also observed Lgi1
expressing cells in the striatum (caudate/putamen), as
shown in figures 8B.1 and 8B.2. Within the thalamus,
Lgi1 protein levels were still weak, although the para-
ventricular thalamic region showed strong expression at
this stage (Figure 8C.1). In the midbrain, expression was
seen in the pretectal and tectal regions, tegmentum, and
both superior and inferior colliculi, which became more
diffuse at this stage. Within the pons, cerebellum and
medulla oblongata the expression was now either weak
or absent. The choroid plexus, however, still shows high
levels of Lgi1 expression (Figure 8B.1).
Lgi1 expression in the later postnatal stages of the
murine brain
In later postnatal stages (P10, P15, and P20), Lgi1
expression levels were essentially the same (Figure 1),
Figure 5 Frontal and sagittal views of LGI1 expression in the
E14.5 mouse brain. A Frontal view (H & E staining) of the head
identifying the regions seen in Figure A.1 which shows Lgi1
expression in the hippocampus (hip) and vomeronasal nerve (vn).
Lgi1 is not detected in nasal septum cartilage (nsc) and shows
punctate expression in the roof of the neopallial cortex (rc). B gittal
view (anti-GFP-peroxidase stained) of whole embryo showing
regions of the brain seen in Figures B.1 and B.2. B.1 Shows Lgi1
expression in the choroid plexus (chp), basal telencephalic plate
(bta), and ventricular zone (vz). B.2 Shows expression of Lgi1 in the
roof of the neopallial cortex (rc) and ventricular zone (vz). Lateral
ventricle (lv); Scale bars = 100 μm.
Figure 6 Lgi1 expression in the E15.5 mouse embryo. A Sagittal view (anti-GFP-peroxidase stained) identifying areas of Lgi1 expression seen
in Figure A.1 and A.2. A.1 Shows strong Lgi1 expression in the ventricular zone (vz) and ganglionic eminence (ge). A.2 Lgi1 was highly
expressed in the lower tegmental neuroepithelium (itgn), mammillary body neuroepithelium (mm), and posterior hypothalamus (hyp). A.3
Shows the expression pattern through the medulla oblongata (mo). B Coronal section (H & E stained) of the head identifying regions seen in
B.1-3. B.1 Shows Lgi1 expressing cells in the eye (e). B.2 Shows Lgi1 expression in the tongue (tg) and B.3 shows Lgi1 expressing cells in the
sphenopalatine ganglion (spg) and Meckel’s cartilage (mc). Lateral ventricle (lv). Scale bars = 100 μm.
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Figure 7 Coronal views of Lgi1 expression pattern in the E18.5 mouse brain. (A). Frontal section (H & E stained) indicating areas shown in
Figures A.1-3. A.1Shows Lgi1 expressing cells in the 3rd ventricle (3rdv), paraventricular hypothalamic nucleus (phn), zona incerta (zi) and anterior
hypothalamic area (hyp). A.2. Shows Lgi1 expression in the cortical plate (cp), intermediate cortical layer (ic), and subventricular zone (subv). A.3.
Shows Lgi1 expression in dentate gyrus (dg), choroid plexus of lateral ventricle (lv), cortex (cx) and hippocampus (hip). Scale bars = 100 μm (A.1,
A.2); 200 μm (A.3).
Figure 8 Coronal and sagittal views of Lgi1 expression in (A) P1 and (B and C) P5 mouse brains. A. Sagittal section of the brain stained
with hematoxylin and eosin used as reference to figures A.1-A.3. A.1. Shows Lgi1 expressing cells in the subventricular zone (sVZ) and stria
terminalis (st) at P1. A.2. Shows Lgi1 expression in hippocampus CA1 and CA3 as well as the dentate gyrus (DG) at P1. A.3. Shows Lgi1
expression in the inferior tectal neuroepithelium (ITN) and superior cerebellar peduncle (SCP) in the P1 brain. B. Coronal section of the brain
stained with hematoxylin and eosin as reference to figures B.1 and B.2. B.1. shows Lgi1 expression in the choroid plexus (Chp) and striatum (str)
at P5. B.2. shows Lgi1 positive cells in the striatum (str) in high magnification. C. Coronal section of the brain stained with hematoxylin and
eosin as reference to figure C.1. C.1. illustrates Lgi1 expressing cells in the paraventricular nucleus (PvN) at P5. Aq = Aqueduct. Scale bars = 100
μm (A.1 to A.3, B.1 and C.1); 20 μm (B.2).
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with strong expression in the choroid plexus, but in
regions such as the neocortex, hypothalamus, midbrain,
hippocampus, and cerebellum, expression was greatly
reduced compared with embryonic stages described
above (Figure 9). Expression in the medulla oblongata
was absent compared to earlier embryonic stages where
its expression was strong. The cerebral cortex now gen-
erally showed weak Lgi1 expression, although Lgi1
expressing cells were seen in areas of the frontal cortex
(Figure 9A.1) and cingulum (Figure 9B.1). The globus
pallidus showed little or no expression, while the stria-
tum (caudate/putamen) showed relatively low levels of
Lgi1 expression. Within the hippocampus, an area typi-
cally showing high levels of Lgi1 in the dentate gyrus,
lower expression levels were observed throughout the
region at these stages. Both the hypothalamus and thala-
mus showed little or no Lgi1 expression. Sagittal sec-
tions through the brain at P5 and P10 demonstrated
that, although the thalamus expressed Lgi1 weakly over-
all, the paraventricular thalamic region appeared to have
stronger Lgi1 expression (Figure 8C.1). In the dorsal
midbrain, the pretectal nuclei showed weak expression
as did the periaqueductal gray, an area surrounding the
cerebral aqueduct, which showed moderate expression.
More posteriorly, juxtaposed to the unstained superior
colliculi, the inferior colliculi showed moderate levels of
Lgi1 expression. In these stages, the pons and medulla
oblongata did not express Lgi1. The cerebellum,
although nearly completely devoid of Lgi1 expression,
showed scattered staining in the Purkinje cells as we
described previously [8]. Figure 9C.1 shows Lgi1 expres-
sion in the granular cell layer of the cerebellar cortex in
P20 brain. Weak or no Lgi1 signal was seen in the
molecular layer of the cerebellar cortex. The choroid
plexus continued to show high expression levels at these
stages.
Co-expression of Lgi1 with Nestin, Doublecortin, and
Beta-III Tubulin
In the developing brain at embryonic stages E9.5 and
E10.5, co-expression of Lgi1 (Figure 10) was seen with
nestin (neural progenitor cell marker), DCX (migrating
neuroblast marker), and beta-III tubulin (neuron-speci-
fic marker) in neural structures such as the optic vesi-
cle epithelium (Figure 10A), cephalic mesenchyme
(Figure 10A), and pretectal neuroepithelium (Figure
10B). As the brain developed (E11.5-E15.5), co-expres-
sion of Lgi1 and nestin/DCX was observed in the
ganglionic eminence (Figure 11A), basal telencephalic
plate (Figure 11B), and medulla oblongata (Figure 12).
At embryonic stage E15.5, co-expression of Lgi1, DCX
and nestin was seen within the subpial and parench-
yma layers of the medulla oblongata (Figure 12). This
Nestin/DCX/Lgi1 co-expression is typical of migrating
neuroblasts. Beta-III Tubulin expression was found for
the first time in the cortical plate at embryonic stage
E14.5 (Figure 13) and overlapped with Lgi1-expressing
cells. Beta-III Tubulin has been suggested to be one of
the earliest markers to signal neuronal commitment in
primitive neuroepithelium. Co-expression of Slug
(neural crest precursor cell marker prior to migration),
RC2 (radial glial cell marker), NG2 (oligodendrocyte
progenitor cell marker), and MAP2 (mature neurons)
was not found in Lgi1-expressing cells at the time
points used in this study.
Discussion
The underlying mechanism behind the genetic predispo-
sition to epilepsy conferred by mutations in the Lgi1
gene is still poorly understood. Although evidence
derived from focused electrophysiological studies impli-
cate abnormalities in synaptic transmission leading to
hyperexcitability [16,17,29], there have also been sugges-
tions that Lgi1 may also have a fundamental role in
brain development [30], which may contribute to the
seizure phenotype. In a BAC transgenic model
Figure 9 Coronal and sagittal views of Lgi1 expression at (A)
P10, (B) P15 and (C) P20 mouse brains. A. Coronal section of the
brain stained with hematoxylin and eosin used as reference to
figure A.1. A.1. Shows Lgi1 expressing cells in the cortex (cx) at P10.
B. Coronal section of the brain stained with hematoxylin and eosin
used as reference to figure B.1. B.1. Shows Lgi1 distribution in the
cortex (cx) and cingulum (cg) at P15. C. Sagittal section of the brain
stained with hematoxylin and eosin used as reference to figure C.1.
C.1. Shows Lgi1 expression in the granular cell layer (gl) of the
cerebellar cortex at P20 but weak or no expression was seen in the
molecular layer (ml). Scale bars = 100 μm
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expressing a truncated Lgi1 protein, for example,
mutant Lgi1 led to neuronal restructuring involving
inhibition of dendritic pruning and an increase in spine
density [29]. Gross anatomical analysis of the brain in
Lgi1 mutant null mice [16,18] however, did not reveal
any major structural defects, although subtle changes
could not be ruled out at this level of analysis. In
humans, although imaging studies have been inconsis-
tent [4,22-24], there are suggestions of abnormalities
and reduced focal brain mass in ADTLE patients. Also,
in our zebrafish studies, knockdown of Lgi1 in embryos
resulted in increased apoptosis in subregions of the
brain, leading to an overall reduction in brain size [31].
With the possibility that Lgi1 may play a role in overall
brain development, and neuronal cell positioning in par-
ticular, it became important to define the structures in
the developing brain that express Lgi1, since these are
the cell lineages that are potentially most affected by
loss of function. In this study we have broadly defined
the temporal and spatial expression pattern in the devel-
oping brain and have demonstrated that, unlike the
more restricted pattern seen in the early postnatal and
Figure 10 Laser scanning confocal images showing co-expression of Lgi1-containg cells with nestin (n) and doublecortin (DCX) in
distinct regions of mouse brain at embryonic stages E9.5 to E15.5. A. Coronal view of the cephalic region at E9.5 showing regions of Lgi1
expression seen in Figure A.1-6. A.1 High magnification of the optic vesicle neuroepithelium (ovn) and cephalic mesenchyme (cm) showing Lgi1
expressing cells which also express DCX A.2 and nestin A.3 overlaid in A.5. Lgi1 expressing cells do not express nestin as showed in Figure A.6.
A.4. Shows DAPI staining for the same region. B. Frontal view (H & E stained) of an E10.5 mouse brain defining regions seen in Figures B.1-6.
B.1. Shows Lgi1 expressing cells in pretectal neuroepithelium (pn) which also express DCX B.2 and nestin B.3 overlaid with DCX B.5 and nestin
B.6. DAPI staining for this region is shown in B.4.
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adult mouse brain, expression of Lgi1 is widespread and
highly orchestrated in a variety of cell types and is not
restricted to differentiated neurons.
Evidence from our previous in vitro gene expression
studies suggested that Lgi1 may have a role in axon gui-
dance and cell migration [32]. Consistent with this sug-
gestion, high levels of Lgi1 expression were found in
regions of the developing brain such as the ganglionic
eminence (GE), medulla oblongata (MO), ventricular
zone (VZ) and telencephalon where mitotic neuronal
precursors are located, and from which they migrate to
populate the cortex and other areas. Lgi1 expressing
cells in the pretectal area, GE, MO and telencephalon
showed coexpression of Lgi1 with DCX (a marker for
migrating neurons) and nestin (a marker for early stage
neural progenitor cells). Nestin is expressed transiently
during development and does not persist through
adulthood, except in neuroprogenitor cells of the sub-
ventricular zone [33,34] which still showed Lgi1 expres-
sion in E18.5 embryos. Interestingly, the presence of
cells co-expressing all three genes in this area suggests
that these cells are migrating immature neurons. Also,
the presence of oriented GFP-positive fibers in the sub-
pial and parenchyma layers of the medulla oblongata
suggest that Lgi1 may be involved in the relocation of
immature neurons in the mouse subpial medullary
region and may play a role in the migration of medul-
lary precerebellar neurons in the caudal medulla [35].
Evidence from studies in adult brain [25,36], suggest
that expression of Lgi1 is largely restricted to the hippo-
campus and cortical neurons. However, in our study we
have shown that Lgi1 expression can be detected in the
cephalic neuroepithelium at E11.5, which coincides with
the first signs of neurogenesis in the mouse [37]. The
Figure 11 Coexpression of neuronal precursor-specific markers with Lgi1 during early development of the brain. A. Sagittal view (anti-
GFP-peroxidase stained) of the E13.5 whole mouse embryo identifying regions shown in Figures A.1-5. A.1. Sagittal section through the
ganglionic eminence (ge) showing Lgi1 expressing cells which also express DCX A.2 and nestin A.3, overlaid of in A.4 and A.5, respectively. B.
Sagittal view (anti-GFP-peroxidase stained) of E14.5 whole embryo identifying regions seen in Figures B.1-3. B.1. Shows Lgi1 expression in the
basal telencephalic plate (btl) compared with DCX expression B.2 which are overlaid in B.3. Scale bar = 100 μm.
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appearance of Lgi1 expression in the cerebral cortex
begins at ~E13.5, and peaks at E18.5. As development
progresses, expression levels in the cortex progressively
diminish. On the other hand, Lgi1 appears not to be
involved in early differentiation and maturation of glial
lineage since Lgi1-expressing cells do not coexpress RC2
(radial glial cells) or NG2 (oligodendrocyte precursor
marker). Even thought differentiated neurons expressed
Lgi1, many of these cells do not express MAP2 at the
observed stages. We speculate that once these cells have
migrated to their final destinations, Lgi1 expression
levels decay.
Lgi1 was also found to be strongly expressed in the
basal telencephalic plates that will develop into the basal
ganglia associated with motor functions. DCX-expressing
cells in the ventral portion of the basal telencephalic
plates also express Lgi1, suggesting that these DCX-Lgi1-
expressing cells migrate and will populate cortical and
subcortical regions. In addition, Marín et al [38] argue
that patterning of the basal telencepahlon is crucial for
the growth of cortical axons as well as for guiding cortical
projections involved in sensory-motor information. The
presence of Lgi1 in migrating neuroblasts is consistent
with a function in cortical and medullar axon guidance,
as suggested by our gene expression studies in model cell
systems [32]. Beta-III tubulin is suggested to be one of
the earliest markers to signal neuronal commitment in
primitive neuroepithelium, and it is accepted as a
neuron-specific protein marker, which is highly
expressed in cortex at birth and then its expression levels
decrease with increasing postnatal development [39].
During brain development, the maturation of neuroblasts
into neurons is accompanied by up-regulation of beta-III
tubulin. Coexpression of Lgi1 and beta-III tubulin was
detected in the ventricular and subventricular zones, as
well as the cortical plate, suggesting a conserved neuro-
genic program in these cells from embryonic stages to
adult life, which further implies that Lgi1 may participate
in normal neuronal development.
We also observed Lgi1 expression in many areas of the
developing sensory system, for example, the tongue (taste
buds), eye, and olfactory bulb. The olfactory system is
anatomically connected to the amygdala, lateral septum,
hypothalamus and the hippocampus, which are part of
the limbic system [40] and which also express Lgi1. This
correlation is consistent with a role for Lgi1 in the devel-
opment of limbic encephalitis [5]. Within the hippocam-
pus, expression levels are found primarily in the dentate
gyrus and scarcely within the CA1-CA3 region of
the pyramidal cell layer. There is evidence that Lgi1 also
regulates intra-hippocampal circuit formation and the
Figure 12 Co-expression of neuronal precursor genes in the
medulla oblongata of E15.5 embryos. A. Sagittal view (anti-GFP-
peroxidase stained) of the E15.5 whole mouse embryo showing
regions described in Figures A.1-5. Nestin expression is identified in
the A.1 subpial region (spr) and A.2 throughout the medulla
oblongata (mo). A.4 shows DCX expression specifically in the
parenchyma (pch) and subpial region (spr) which are overlaid in
A.3, compared with DAPI staining A.5. Scale bars = 100 μm.
Figure 13 Laser scanning confocal images showing co-
expression of Lgi1 and beta-III tubulin in the cortical plate and
ventricular zone of mouse brain at embryonic stage E14.5. A.
Sagittal view (anti-GFP-peroxidase stained) of whole embryo
indicating regions shown in Figures A.1-7. A.1. Shows Lgi1
expressing cells through the ventricular zone (vz) and cortical plate
(cp). A.2. Shows beta-III tubulin expression in the cortical plate,
overlaid in A.3 and shown in higher magnification in A.4 and A.5
respectively and contrasted in DAPI in A.6. A.7. Shows Lgi1
expressing cells overlaid with beta-III tubulin in the marginal zone
(mz), cortical plate (cp), and ventricular zone (vz). Beta-III tubulin is
not expressed in intermediate zone (iz). Lgi1 signal is seen in
intermediate (iz) and subventricular (sbv) zones. Lateral ventricle (lv).
Scale bars = 20 μm.
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dentate gyrus plays a critical role in seizures, since it
appears to have low epileptogenic thresholds [29].
Although thalamic protein levels are weak overall, the
paraventricular thalamic area expresses Lgi1. According
to Huang et al [41], the thalamic paraventricular nucleus
receives the highest innervation from hypothalamic
hypocretin/orexin neurons, generating substantial excita-
tion of the medial prefrontal cortex. Major inputs into
the anterior thalamic group are from the hypothalamus,
the hippocampus, and the tectum while output from this
region is mainly to the cingulate gyrus. In the developing
mouse eye, Lgi1 expression was seen in the optic vesicle,
optic stalk and optic cup, as well as the neural retina and
the retinal pigment epithelium. Lgi1 expression is seen in
the retinal ganglion layer, and dominant-negative muta-
tions in transgenic mice lead to abnormal postnatal prun-
ing of retinal axons in the visual relay thalamus [42]. In
zebrafish studies, Lgi1 expression was seen in the epithe-
lium surrounding the lumen of the optic vesicle [43] and
interestingly, in early zebrafish embryos, loss of Lgi1
results in abnormal eye development [31], supporting its
critical role in development of this organ.
Conclusions
Several general patterns of Lgi1 distribution were apparent
during embryonic brain development. Lgi1 expression
appears to spread throughout the dorsal-most brain struc-
tures with only weak levels in the ventral regions in early
embryo stages within the medulla oblongata showing the
strongest expression. This dorsoventral differentiation also
appears in the hippocampus, where the dentate gyrus
showed more robust expression. Lgi1 expression also
appears to follow a superficial to deep, as well as a caudal
to cephalic axis. At E10.5, the strongest signal was found
in the surface ectoderm, as well as the infundibular recess
of the diencephalon and dorsal midbrain in the pretectal
neuroepithelium. As development progresses, Lgi1 expres-
sion moves interiorly into the neocortex and other more
caudal structures, expression in the pretectum and dience-
phalon areas begins to subside, as shown by weak expres-
sion in basal ganglia and thalamic nuclei, although
expression in the paraventricular thalamic nucleus remains
strong at P5. Overall, the spatial and temporal expression
profile for Lgi1 during embryogenesis and postnatal stages
is consistent with the idea that it plays an important role
in normal brain development, especially neuronal migra-
tion and synapse formation.
Methods
Lgi1-EGFP mice
The generation of the LGI1-EGFP BAC transgenic mice
has been reported previously [8]. Mice were housed
under standard conditions and treated in accordance
with the Guidelines for the Care and Use of Laboratory
Animals of Medical College of Georgia.
RT-PCR
Mouse brains were isolated and immediately frozen in
liquid nitrogen. Using a polytron homogenizer, whole
embryos or brains were then homogenized in trizol
(Invitrogen) and RNA was isolated as recommended by
the manufacturer. Lgi1 was amplified using 5’-GATC-
CATTCCACGCACCGTTCCTC3’ (Forward) and
5’TCTTCTCTACGTGGTCCCATTCCA-3’ (Reverse)
primer sequences and resolved in 1% agarose gels.
Histology and confocal microscopy
Embryos were removed from pregnant female mice and
fixed in a 4% paraformaldehyde solution in PBS for at
least 24 hours. Embryos were then first dehydrated in
stepped concentrations of ethanol solution from 70% to
100% and then placed in xylene before being embedded
in paraffin. Brains from neonates were dissected and
quickly fixed in 4% paraformaldehyde solution and simi-
larly mounted in paraffin. 7 μm coronal and sagittal sec-
tions were collected onto plus-charged glass slides
(Fisher Scientific, Pittsburgh, PA). After deparaffiniza-
tion in xylene, and rehydration, the tissues were permea-
bilized with 0.1% triton X-100 in PBS. Processed
sections were then reacted with specific primary and
secondary antibodies (see below). Brightfield and confo-
cal images were obtained using a Zeiss microscope and
LSM500 software. Several different reference resources
were used as an aid in identification of anatomical struc-
tures [44-48].
Antibodies
Immunogen affinity-purified polyclonal anti-EGFP anti-
body (Abcam, ab6556) was used for confocal analysis.
Anti-NG2, anti-Slug, and Doublecortin (sc-18) antibodies
were obtained from Santa Cruz Biotechnology, Inc. Anti-
Nestin (MAB353) and Anti-Beta III Tubulin (MAB5564)
monoclonal antibodies were obtained from Millipore
Corporation. Anti-MAP2 was from Cell Signaling, and
Anti-RC2 was from UC Davis. The secondary antibodies
used for primary antibody detection were peroxidase
conjugated anti-rabbit, anti-goat, and anti-mouse IgG, all
obtained from Jackson ImmunoResearch Laboratories.
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